Clinical Trial Update: The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer. Diagnosis of Pancreatic Cancer

View source ↗

Summary

A clinical trial exploring DNA nanomachines to detect microRNA in blood as a diagnostic tool for pancreatic cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Pancreas Adenocarcinoma, MicroRNA | Status: RECRUITING